$4.95
-0.0600 (-1.20%)
At Close: Jun 03, 2026
Bausch + Lomb Launches Blink® Nourish Lubricating Eye Drops and Blink Boost Lubricating Eye Drops in the United States
06:59am, Wednesday, 04'th Jun 2025
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launc
Why Is Bausch (BHC) Down 13% Since Last Earnings Report?
12:36pm, Friday, 30'th May 2025
Bausch (BHC) reported earnings 30 days ago. What's next for the stock?
The facial injectable market is poised for significant growth, with a rise from US$18.310 billion in 2025 to US$32.083 billion by 2030, driven by an 11.87% CAGR. Increasing emphasis on physical appear
Bausch + Lomb Launches New LUMIFY® Preservative Free Redness Reliever Eye Drops in the United States
06:59am, Wednesday, 21'st May 2025
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launc
Bausch Health Announces 2025 Annual Meeting of Shareholder Results
04:15pm, Wednesday, 14'th May 2025
LAVAL, QC / ACCESS Newswire / May 14, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced the election of the 10 directors nominated at its 2025 annual meeting of shareholders ("An
New Strong Sell Stocks for May 13th
07:30am, Tuesday, 13'th May 2025
ALTI, AMRK and BHC have been added to the Zacks Rank #5 (Strong Sell) List on May 13, 2025.
Bausch + Lomb Receives European CE Mark Approval for Preloaded LuxLife® Full Range of Vision Intraocular Lens
07:00am, Wednesday, 07'th May 2025
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced CE Mark approv
New analysis suggests efficacy of Xifaxan to mitigate OHE rehospitalizations irrespective of treatment history LAVAL, QC / ACCESS Newswire / May 6, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:B
Bausch Health Q1 Earnings and Revenues Miss Estimates, Stock Down
10:50am, Thursday, 01'st May 2025
BHCs first-quarter 2025 adjusted earnings and revenues miss estimates. Salix performs lower than expected.
Bausch (BHC) Reports Q1 Earnings: What Key Metrics Have to Say
09:31pm, Wednesday, 30'th Apr 2025
The headline numbers for Bausch (BHC) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates
Bausch Health (BHC) Q1 Earnings and Revenues Lag Estimates
09:05pm, Wednesday, 30'th Apr 2025
Bausch Health (BHC) came out with quarterly earnings of $0.59 per share, missing the Zacks Consensus Estimate of $0.83 per share. This compares to earnings of $0.59 per share a year ago.
Bausch Health Companies Inc. (BHC) Q1 2025 Earnings Call Transcript
07:51pm, Wednesday, 30'th Apr 2025
Bausch Health Companies Inc. (NYSE:BHC ) Q1 2025 Earnings Conference Call April 30, 2025 5:00 PM ET Company Participants Garen Sarafian - IR Thomas Appio - CEO Jean-Jacques Charhon - EVP & CFO Confere
Bausch Health Announces First Quarter 2025 Results
04:05pm, Wednesday, 30'th Apr 2025
First Quarter Consolidated Revenues of $2.26 billion, up 5% on a Reported basis and 6% on an Organic (non-GAAP) 1 basis over the prior year period GAAP Net Loss Attributable to Bausch Health Companies
Bausch Health Announces Health Canada Clearance of Solta Medical's Thermage(R) FLX System
08:00am, Tuesday, 29'th Apr 2025
A Long-Awaited Advancement in Non-Invasive Radiofrequency Skin Tightening Is Now Approved for the Canadian Market LAVAL, QC / ACCESS Newswire / April 29, 2025 / Bausch Health Companies Inc. (NYSE:BHC)
Will Bausch (BHC) Beat Estimates Again in Its Next Earnings Report?
01:15pm, Thursday, 24'th Apr 2025
Bausch (BHC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Sign In
Buy BHC